Xospata 40 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FWKSS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,934
Award facts
- Contract value 100% obligated
- $53,933.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of XOSPATA 40 mg tablets (90-count packages) valued at $53,933.82. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under an existing indefinite delivery contract vehicle. The ultimate completion date is October 9, 2025, and performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. XOSPATA (gilteritinib) is a targeted cancer therapy used in the treatment of acute myeloid leukemia, supporting the Department of Defense's pharmaceutical supply needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and other critical medical commodities. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FWKSS?
SPE2DB25FWKSS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FWKSS worth?
The government has obligated $53,934 on SPE2DB25FWKSS.
Is contract SPE2DB25FWKSS an order under another contract?
Yes. SPE2DB25FWKSS is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKSS competed?
The extent of competition for SPE2DB25FWKSS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award